Lastacaft Adverse Reactions




Full Prescribing Info
Adverse Reactions
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
Ocular Adverse Reactions: The most frequent ocular adverse reactions, occurring in <4% of LASTACAFT‐treated eyes, were eye irritation, burning and/or stinging upon instillation, eye redness/conjunctival hyperemia and eye pruritus/application site pruritus.
Non‐ocular Adverse Reactions: The most frequent non‐ocular adverse reactions, occurring in <3% of subjects with LASTACAFT‐treated eyes, were nasopharyngitis, headache and influenza. Some of these events were similar to the underlying disease being studied.
Postmarketing Experience: The following adverse reactions have been identified during postmarketing use of LASTACAFT in clinical practice. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made.
Eye Disorders: Conjunctivitis, Eye discharge, Eye swelling, Erythema of eyelid, Eyelid edema, Lacrimation increased and Vision blurred.
Immune System Disorders: Hypersensitivity reaction including symptoms or signs of eye allergy, swelling of the face and allergic dermatitis.
Nervous System Disorders: Somnolence.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in